Cargando…
NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix
BACKGROUND: NQO1 (NAD(P)H: quinone oxidoreductase-1), located on chromosome 16q22, functions primarily to protect normal cells from oxidant stress and electrophilic attack. Recent studies have revealed that NQO1 is expressed at a high level in most human solid tumors including those of the colon, br...
Autores principales: | Ma, Yue, Kong, Jienan, Yan, Guanghai, Ren, Xiangshan, Jin, Dan, Jin, Tiefeng, Lin, Lijuan, Lin, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058702/ https://www.ncbi.nlm.nih.gov/pubmed/24912939 http://dx.doi.org/10.1186/1471-2407-14-414 |
Ejemplares similares
-
NQO1 protein expression predicts poor prognosis of non-small cell lung cancers
por: Li, Zhenling, et al.
Publicado: (2015) -
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015) -
Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012) -
Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
por: Ji, Meiying, et al.
Publicado: (2017) -
High expression of ezrin predicts poor prognosis in uterine cervical cancer
por: Kong, Jienan, et al.
Publicado: (2013)